The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

The effects of nicotine (NI), silver acetate (SA), and ordinary (PL) chewing gum on the cessation of smoking were compared through ratings on six smoking types and physiological nicotine dependence (F-score) in a placebo-controlled and randomized study that included 496 smokers in a group-support setting.

Ratings on smoking types 1, 3, 4, 5, and 6 and F-score were related to success rates.

Who Took Part

The age groups tagged for this paper are adults and middle-aged adults, both men and women.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Some participants received a placebo instead of Therapeutic nicotine (patch, non-peptide), giving a reference point.

What Was Measured

The effects of nicotine (NI), silver acetate (SA), and ordinary (PL) chewing gum on the cessation of smoking were compared through ratings on six smoking types and physiological nicotine dependence (F-score) in a placebo-controlled and randomized study that included 496 smokers in a group-support setting.

Ratings on smoking types 1, 3, 4, 5, and 6 and F-score were related to success rates.

Topics PubMed links to this paper include Acetates, Acetic Acid, Chewing Gum, Nicotine, Smoking and Smoking Cessation.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Therapeutic nicotine (patch, non-peptide).

The publication is from 1991 (The International journal of the addictions), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.